Albany, NY (PRWEB) January 09, 2015
Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales(at)researchmoz(dot)us
This report answers a number of key questions pertaining to the China hemodialysis market. Hemodialysis, also simply referred to as HD, is a therapy that is carried out on patients suffering from chronic or acute renal failure.
To Browse a Full Report with TOC: http://www.researchmoz.us/research-report-on-hemodialysis-industry-in-china--2014-2018-report.html
What makes the China hemodialysis market report important? Globally, there are an estimated 2.2 million people suffering from end stage renal diseases (ESRD) also known as uremia. Of these 2.2 million patients, about 89% are reported to be undergoing hemodialysis. Given the dense population in China, many of these patients are located in the country. Till now, the trend has been that most dialysis patients were either in the United States or Europe as these regions comprise developed countries where patients are able to afford the high cost of hemodialysis.
Similarly, the numbers of patients that constitute the hemodialysis market in developing countries are comparatively low because of the high cost of treatment and a low general level of awareness about the therapy. But things are changing rapidly and it is now being observed that in fast developing countries, such as China, Brazil and India, the growth rate of dialysis patients is well above 15%. The growth rate of the dialysis patient pool in Europe and the US (3% to 5%) pales in comparison.
The report also observes that of all patients suffering from ESRD, only about 10%-20% receive dialysis in developing countries. In contrast, the proportion is as high as 80% in the United States and Europe.
This report focuses on the China hemodialysis market because the increase in per capita income here has been phenomenal. This has given patients the ability to spend on critical yet expensive procedures such as hemodialysis. With this, the hemodialysis market in China is on an upswing, and is moving ahead at a very rapid speed. The reason for hemodialysis being expensive is the high cost of devices and equipment used for the procedure, the need of skilled medical professionals to carry out the procedure, and the expensive drugs that are used for treating renal failure.
Since all of these components are very critical to the overall hemodialysis market, this report studies them in great detail. The hemodialysis instruments segment is split into dialysis machines, dialysis pipelines, and dialyzer. The latter is a component that faces high technical barriers, but still accounts for a predominant market share. According to the estimates of the report, the hemodialysis market China is valued over CNY 5 billion. The domestic share of this market is pegged at about 30%. Here, the unique trend is that imports are rapidly being substituted by domestically manufactured products. The market for dialysis machines is dominated by multinational brands.
As for the drugs that constitute a vital portion of the hemodialysis market, the leading players are EPO and heparin. Both of these are largely produced within China. Within the hemodialysis market, the cost of services is incurred on healthcare labor as well as beds and ancillary services.
The report projects that by the year 2020, the total number of patients diagnosed with ESRD globally, will be about 4.2 million; of these, over 1 million will be in China alone. This reiterates the importance of the hemodialysis market in China. The CAGR of the hemodialysis market in China will be over 20%, and the market will surpass a value of CNY 70 billion by 2020.
All Reports of this Category Here: http://www.researchmoz.us/medical-equipments-market-reports-109.html